期刊文献+

E-钙黏蛋白及三阴性表达与乳腺癌临床病理特征的关系 被引量:3

Correlation of E-cadherin and three indexes expressions with clinicopathological features of breast cancer
原文传递
导出
摘要 目的探讨E-钙黏蛋白及三阴性表达与乳腺癌临床、病理特征的关系。方法浸润性乳腺癌患者280例,采用免疫组织化学法检测雌激素受体、孕激素受体、人类表皮生长因子受体-2及E-钙黏蛋白表达情况,分析E-钙黏蛋白表达及三阴性与患者临床病理特点间关系。结果 280例患者中三阴性乳腺癌患者32例(TNBC组),非三阴性乳腺癌患者248例(非TNBC组);TNBC组肿瘤直径>2cm、组织病理分级Ⅱ和Ⅲ级、淋巴管有浸润比例及E-钙黏蛋白表达阴性率(75.0%、68.7%、46.9%、71.9%)高于非TNBC组(51.2%、46.0%、21.0%、33.5%),差异有统计学意义(P<0.05);淋巴结有转移者E-钙黏蛋白表达阴性率(46.1%)高于淋巴结无转移者(29.5%),差异有统计学意义(P<0.05)。结论 E-钙黏蛋白及三阴性表达与乳腺癌多种临床病理特点有相关性。 Objective To investigate the correlation of the expression of E-cadherin and negative expressions of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 with the clinicopathological features of breast cancer. Methods The expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2 and E-cadherin were detected by using immunohistochemical method in 280 cases of invasive breast carcinoma. The correlation of the expression of E-cadherin and the negative expressions of these three indexes with the different clinicopathological features of breast cancer was analyzed. Results In these 280 patients, 32 suffered from triple negative breast cancer (TNPC) and 248 suffered from non TNBC. The rates of tumor diameter larger than 2 cm, the pathological stage of Ⅱ and Ⅲ degree, lymph-vascular invasion, and the negative expression of E-cadherin were 75. 0%, 68. 7%, 46.9% and 71.9% in TNBC patients, significantly higher than those in non-TNBC patients (51.2%, 46.0%, 21.0% and 33.5%), which showed significant differences (P〈0.05). The rate of the negative expression of E-cadherin was 46. 1% in patients with lymph node metastasis, obviously higher than that in those without lymph node metastasis (29.5%), showing a significant difference (P〈0.05). Conclusion The expression of E-cadherin and the negative expressions of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 are correlated with the clinicopathological features of breast cancer.
作者 孔德娣
出处 《中华实用诊断与治疗杂志》 2013年第9期854-856,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 乳腺癌 三阴性乳腺癌 E-钙黏蛋白 免疫组织化学 Breast cancer triple negative breast cancer E cadherin immunohistochemistry
  • 相关文献

参考文献9

二级参考文献37

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1366
  • 2杨景,柳凤轩,阎晓初,贺光友,刘丽梅.KAI1基因表达与大肠癌发生、发展的关系[J].肿瘤防治研究,2005,32(4):209-212. 被引量:1
  • 3沈岚,谭洁.熊果酸诱导结肠癌HT-29细胞凋亡与凋亡相关基因的关系[J].实用诊断与治疗杂志,2006,20(11):784-786. 被引量:8
  • 4Muneyuki T, Watanabe M, Yamanaka M, et al. KAI1/CD82 expression as a prognostic factor in sporadic colorectal cancer[J].Anticancer Res,2001,21(5) :3581-3587.
  • 5Higashiyama M, Kadama K, Yokouchi H, et al. KAI1/CD82 expression in non-small cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis[J]. Cancer, 1998,83(3):466-474.
  • 6Wang X, Zhang J, Fan M, et al, The expression of E cadherin at the invasive tumor front of oral squmaous cell carcinoma:immunohistochemical and RT PCR analysis with clinicalpathological correlation[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009,107(4):547-554.
  • 7Joe B K, Lee J Y, Lim Y, et al. Effecl of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells[J]. Biochem Biophys Res Commun, 2007,359 (3) : 703-708.
  • 8Lan C, Liu J M, Liu T W, et al. erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2- in immunohistochemical analysis[J]. Am J Clin Pathol,2005,124(1) :97-102.
  • 9Dean-Colomb W, Esteva F J. HER2-positive breast cancer: herceptin and beyond[J]. Eur J Cancer, 2008,44(18):2806-2812.
  • 10Rosenberg C L. Polysomy 17 and HER 2 amplification: true, true, and unrelated[J]. J Clin Oncol,2008,26(30) :4856-4858.

共引文献21

同被引文献18

  • 1Bauer K, Brown M, Cress R, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)- negative, and HER2-negative invasive breast cancer, the so- called triple-negative phenotype: a population-based study from the california cancer registry[J]. Cancer, 2007, 109 (9) : 1721- 1728.
  • 2American Joint Committee on Cancer. AJJC Cancer Staging Manual[M]. 5th ed. Philadelphia (PA) : Lippineott-Raven, 1997..103-108.
  • 3Ktimmel A, Kiimmel S, Barinoff J, et al. Prognostic factors for local, coco-regional and systemic recurrence in early-stage breast cancerl-J3. Geburtshilfe Frauenheilkd, 2015,75 (7) : 710-718.
  • 4Finch AP, Lubinski J, Mller P, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation[J]. J Clin Oncol,2014,32(15) : 1547-1553.
  • 5Fulford LG, Easton morphological features DF, Reis-Filho JS, et predictive for the basal grade 3 invasive ductal carcinoma of al. Specific phenotype in breast [J]. Histopathology, 2006,49 (1) : 22-34.
  • 6Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours[J]. Histopathology,2006,49 (1) :10-21.
  • 7Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res,2007,13(1):4429-4434.
  • 8Tischkowitz M, Brunet JS, B6gin LR, et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer[J]. BMC Cancer,2007,7 : 134.
  • 9阿迪力.阿不力,杨海轩.三阴乳腺癌临床特征分析[J].临床医学,2010,30(9):68-69. 被引量:4
  • 10李世超,齐晓伟,范林军.美国临床肿瘤学会和美国病理学家学会乳腺癌雌激素/孕激素受体免疫组化检测指南[J].中华乳腺病杂志(电子版),2011,5(3):47-47. 被引量:22

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部